Nitto Avecia · 2 days ago
Vice President, Research and Development
Nitto Avecia is a biopharmaceutical company focused on the development of oligonucleotides and drug delivery technologies. The Vice President of Research and Development will provide technical and strategic leadership for analytical, process, and biopharma development functions, ensuring compliance with budget and operational efficiencies.
BiotechnologyManufacturingPharmaceutical
Responsibilities
Provide scientific and technical input to assess potential business opportunities and new ventures and identify areas or equipment and capabilities the team should consider for evaluation
Lead and direct the plans and activities of assigned functional area(s), ensuring safe and GMP-compliant operations which adhere to budget and schedule
Participate in corporate development of methods, techniques, and evaluation criteria for meeting performance objectives
Implement key performance indicators (KPIs) to measure operational performance and drive improvements across all assigned functional areas and communicate progress toward meeting company goals to the leadership monthly, quarterly, and annually
Ensure implementation of continued operational efficiencies with reliable schedule adherence, lower costs, and increased productivity by managing a portfolio of strategic continuous improvement projects, applying Lean and Six Sigma philosophies accordingly, and reporting progress results periodically to senior management
Serve as decision-making authority for assigned functional area(s) by providing approvals on hiring and termination, performance appraisals, performance improvement plans, merit increases, and employee status changes (such as promotion or reorganization) with consideration of project load, organizational design, and budget
Enhance business growth by understanding customer needs and working with Business Development on RFPs, presenting department capabilities and coming up with technical solutions to secure new business with existing and new customers
Participating in scientific community by attending conferences and being on external committees is vital to the company strategy of being best in class CDMO
Mentor, motivate, and challenge employees to develop skills and drive high performance
Execute management duties in accordance with company policies and applicable laws, including interviewing, hiring, and training employees; planning, assigning, and directing work; appraising performance; rewarding and disciplining employees; addressing complaints and resolving problems
Oversee workplace cleanliness by implementing, managing, and monitoring the 5S method of organization
Promote a culture of safety and support site safety initiatives
Qualification
Required
Ph.D. with 15+ years, or MS with 18+ years of relevant pharmaceutical industry experience
Advanced knowledge of FDA and ICH guidelines related to drug product and drug substance development for regulatory submissions
Expertise in process development using QbD techniques, with knowledge of parenteral products including small molecules, oligonucleotides, proteins, LNPs, pharmaceutical polymers, emulsions, and ophthalmic formulations
Advanced knowledge of USP, European Pharmacopoeia, and other compendial procedures
Demonstrated scientific contributions through posters, presentations, patents, and regulatory submissions (FDA, EMEA, others)
Strong interpersonal and communication and the ability to effectively present to and engage with managers, customers, and employees
Company
Nitto Avecia
Oligonucleotides are giving rise to a new generation of therapeutics—and Nitto Avecia is helping lead the way.
H1B Sponsorship
Nitto Avecia has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (4)
2024 (7)
2023 (6)
2022 (10)
2021 (11)
2020 (5)
Funding
Current Stage
Late StageTotal Funding
unknown2011-02-03Acquired
Company data provided by crunchbase